Question 1

What is Ottimo Pharma?

Accepted Answer

Ottimo Pharma is a Entity.

Question 2

How often does Ottimo Pharma appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Ottimo Pharma first tracked by Ergen?

Accepted Answer

First tracked on May 18, 2026.

Question 4

When was Ottimo Pharma last mentioned in news?

Accepted Answer

Last active on May 18, 2026.

Question 5

What is Ottimo Pharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Ottimo Pharma in global news coverage?

Accepted Answer

Attention score of 3, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Ottimo Pharma?

Accepted Answer

LOTTE Biologics, Ottimo Pharma expand antibody agreement (May 18, 2026, 6 articles).

Question 8

How did the "LOTTE Biologics, Ottimo Pharma expand antibody agreement" event impact Ottimo Pharma?

Accepted Answer

Ottimo Pharma has expanded its antibody manufacturing agreement with Lotte Biologics, demonstrating confidence in Lotte Biologics' capabilities. This collaboration will advance its biparatopic antibody, OTP-01, toward launch readiness, accelerating its development.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.